The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A qualitative exploration of perceptions of the value of wearable activity monitors among prostate cancer survivors undergoing androgen deprivation therapy.
 
Brandon Noorvash
No Relationships to Disclose
 
Tyra Nguyen
No Relationships to Disclose
 
Aubrey Jarman
No Relationships to Disclose
 
Haleigh Bellerose
No Relationships to Disclose
 
Katherine Barnhill
No Relationships to Disclose
 
Carolina Raines
No Relationships to Disclose
 
Howard M. Sandler
Consulting or Advisory Role - Janssen
Other Relationship - Caribou Publishing
 
Edwin Melencio Posadas
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Research Funding - PFizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
Expert Testimony - Shook, Hardy & Bacon L.L.P.
 
Jun Gong
Honoraria - Amgen; Astellas Pharma; AVEO; Basilea Pharmaceutical; Bayer; Clinical Congress Consultants; Eisai; Elsevier; EMD Serono; Exelixis; HalioDx; Incyte; Janssen Biotech; Natera; Pfizer/Myovant; QED Therapeutics
Consulting or Advisory Role - Amgen; Astellas Pharma; AVEO; Basilea; Bayer; Clinical Congress Consultants; Eisai; Elsevier; EMD Serono/Merck; Exelixis; HalioDx; Incyte; Janssen Biotech; MJH Life Sciences; Natera; OncLive/MJH Life Sciences; Pfizer/Myovant; QED Therapeutics; Seagen
Patents, Royalties, Other Intellectual Property - PCT/US2021/043961 provisional patent on glutamine and cancer; U.S. Provisional Application Serial No. 63/315,895 on methylated ctDNA markers
 
Stephen J. Freedland
Employment - Genomic Health (I)
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; LynxDx; Merck; Myovant Sciences; Pfizer; Sanofi; Tempus
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Gillian Gresham
No Relationships to Disclose
 
Celina H. Shirazipour
No Relationships to Disclose